Intravenous hydration according to current guidelines in the prevention of contrast induced nephropathy-the AMACING trial.
暂无分享,去创建一个
J. Wildberger | R. Rennenberg | P. Nelemans | B. Essers | E. Nijssen | M. Vermeeren | V. van Ommen | M. M. Janssen
[1] J. Wildberger,et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial , 2017, The Lancet.
[2] D. Kallmes,et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. , 2013, Radiology.
[3] R. Mehran,et al. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.